Sulpistad is indicated for the treatment of acute and chronic schizophrenic disorders, in which positive symptoms (such as delusions, hallucinations, thought disorders) and/or negative symptoms (such as blunted affect, emotional and social withdrawal) are prominent, including patients characterised by predominant negative symptoms.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Đăng xuất
